Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The National Cancer Institute's Radiation Research Program, in collaboration with the Radiosurgery Society, hosted a workshop called Understanding High-Dose, Ultra-High Dose Rate and Spatially Fractionated Radiotherapy on August 20 and 21, 2018 to bring together experts in experimental and clinical experience in these and related fields. Critically, the overall aims were to understand the biological underpinning of these emerging techniques and the technical/physical parameters that must be further defined to drive clinical practice through innovative biologically based clinical trials.

Original publication

DOI

10.1016/j.ijrobp.2020.03.028

Type

Journal article

Journal

Int J Radiat Oncol Biol Phys

Publication Date

15/07/2020

Volume

107

Pages

766 - 778

Keywords

Clinical Trials as Topic, Dose Fractionation, Radiation, Humans, Radiation Dosage, Radiotherapy, Treatment Outcome